Last news

Jérôme Lemoine will be a speaker at the 4th International…

posted January 30, 2026

He will present Messenger Biopharma’s second-generation capless mRNA, which will ...Read More

Jérôme Lemoine will be a speaker at the European mRNA…

posted March 01, 2025

In Berlin, on June 16, 2025, he will present Messenger ...Read More

 

Find us

Messenger Biopharma is perfecting a biotechnology of in vivo mRNA transfection, which has been patented. This biotechnology tends to optimize the process of mRNA delivery to mammalian cells, as well as the mRNA sequence.